{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Cilazapril  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cilazapril. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cilazapril  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "cilazapril",
    "trial_2_text": "Cilazapril  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Cilazapril Supplement: 60 participants will take Cilazapril 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cilazapril. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cilazapril  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.205993190407753,
      "78": 0.1867876648902893,
      "17": 0.12855248153209686,
      "173": 0.12213213741779327,
      "177": 0.11640065908432007,
      "123": 0.11084412783384323,
      "9": 0.1090874895453453,
      "37": 0.09970656037330627,
      "20": 0.09866209328174591,
      "46": 0.09516613930463791,
      "67": 0.0927698165178299,
      "228": 0.0925748199224472,
      "79": 0.09156853705644608,
      "2": 0.08688721805810928,
      "68": 0.0835418626666069,
      "21": 0.08349636942148209,
      "64": 0.07868669182062149,
      "14": 0.07781565189361572,
      "189": 0.0759192556142807,
      "200": 0.07184706628322601,
      "49": 0.0703783929347992,
      "188": 0.06686292588710785,
      "350": 0.06544607877731323,
      "86": 0.06528569012880325,
      "193": 0.06442410498857498,
      "77": 0.0642537921667099,
      "101": 0.06330505758523941,
      "114": 0.06051577627658844,
      "72": 0.05906325578689575,
      "5": 0.05811534449458122,
      "85": 0.0555601492524147,
      "126": 0.054286740720272064,
      "243": 0.05281587317585945,
      "122": 0.0525023490190506,
      "29": 0.05135470628738403,
      "239": 0.05068732425570488,
      "151": 0.04899812117218971,
      "139": 0.04709916561841965,
      "76": 0.04641959071159363,
      "194": 0.04557576775550842,
      "179": 0.04491553083062172,
      "234": 0.04370957612991333,
      "28": 0.04368629679083824,
      "131": 0.04366738721728325,
      "27": 0.04364781826734543,
      "144": 0.04338258504867554,
      "61": 0.04336947947740555,
      "102": 0.04301292449235916,
      "104": 0.04278174787759781,
      "276": 0.04254522547125816,
      "180": 0.04194692522287369,
      "147": 0.04115254431962967,
      "355": 0.040638599544763565,
      "1": 0.03923908993601799,
      "38": 0.03867965191602707,
      "96": 0.03820621222257614,
      "130": 0.037652935832738876,
      "132": 0.03725914657115936,
      "92": 0.03720485791563988,
      "297": 0.03671009838581085,
      "69": 0.036002952605485916,
      "262": 0.03574244678020477,
      "116": 0.03553052991628647,
      "18": 0.03543636575341225,
      "154": 0.03494856134057045,
      "261": 0.03486095741391182,
      "396": 0.03468750789761543,
      "142": 0.034525662660598755,
      "164": 0.03399553894996643,
      "191": 0.03390756621956825,
      "100": 0.03384367749094963,
      "4": 0.033169813454151154,
      "282": 0.032965708523988724,
      "75": 0.03287173807621002,
      "269": 0.032810866832733154,
      "30": 0.03259929269552231,
      "82": 0.03227704018354416,
      "288": 0.03176761046051979,
      "466": 0.031480953097343445,
      "36": 0.031450312584638596,
      "204": 0.030573096126317978,
      "422": 0.030568119138479233,
      "339": 0.02975134365260601,
      "33": 0.029749440029263496,
      "186": 0.029392119497060776,
      "35": 0.02914775349199772,
      "249": 0.028177309781312943,
      "508": 0.0281395073980093,
      "121": 0.028062963858246803,
      "441": 0.02795802801847458,
      "31": 0.02774726413190365,
      "341": 0.027560217306017876,
      "97": 0.027513418346643448,
      "456": 0.026761643588542938,
      "153": 0.02674262225627899,
      "382": 0.02673453837633133,
      "361": 0.026545453816652298,
      "221": 0.02636880986392498,
      "256": 0.025757411494851112,
      "371": 0.02529013156890869
    },
    "trial_2_ae": {
      "87": 0.205993190407753,
      "78": 0.1867876648902893,
      "17": 0.12855248153209686,
      "173": 0.12213213741779327,
      "177": 0.11640065908432007,
      "123": 0.11084412783384323,
      "9": 0.1090874895453453,
      "37": 0.09970656037330627,
      "20": 0.09866209328174591,
      "46": 0.09516613930463791,
      "67": 0.0927698165178299,
      "228": 0.0925748199224472,
      "79": 0.09156853705644608,
      "2": 0.08688721805810928,
      "68": 0.0835418626666069,
      "21": 0.08349636942148209,
      "64": 0.07868669182062149,
      "14": 0.07781565189361572,
      "189": 0.0759192556142807,
      "200": 0.07184706628322601,
      "49": 0.0703783929347992,
      "188": 0.06686292588710785,
      "350": 0.06544607877731323,
      "86": 0.06528569012880325,
      "193": 0.06442410498857498,
      "77": 0.0642537921667099,
      "101": 0.06330505758523941,
      "114": 0.06051577627658844,
      "72": 0.05906325578689575,
      "5": 0.05811534449458122,
      "85": 0.0555601492524147,
      "126": 0.054286740720272064,
      "243": 0.05281587317585945,
      "122": 0.0525023490190506,
      "29": 0.05135470628738403,
      "239": 0.05068732425570488,
      "151": 0.04899812117218971,
      "139": 0.04709916561841965,
      "76": 0.04641959071159363,
      "194": 0.04557576775550842,
      "179": 0.04491553083062172,
      "234": 0.04370957612991333,
      "28": 0.04368629679083824,
      "131": 0.04366738721728325,
      "27": 0.04364781826734543,
      "144": 0.04338258504867554,
      "61": 0.04336947947740555,
      "102": 0.04301292449235916,
      "104": 0.04278174787759781,
      "276": 0.04254522547125816,
      "180": 0.04194692522287369,
      "147": 0.04115254431962967,
      "355": 0.040638599544763565,
      "1": 0.03923908993601799,
      "38": 0.03867965191602707,
      "96": 0.03820621222257614,
      "130": 0.037652935832738876,
      "132": 0.03725914657115936,
      "92": 0.03720485791563988,
      "297": 0.03671009838581085,
      "69": 0.036002952605485916,
      "262": 0.03574244678020477,
      "116": 0.03553052991628647,
      "18": 0.03543636575341225,
      "154": 0.03494856134057045,
      "261": 0.03486095741391182,
      "396": 0.03468750789761543,
      "142": 0.034525662660598755,
      "164": 0.03399553894996643,
      "191": 0.03390756621956825,
      "100": 0.03384367749094963,
      "4": 0.033169813454151154,
      "282": 0.032965708523988724,
      "75": 0.03287173807621002,
      "269": 0.032810866832733154,
      "30": 0.03259929269552231,
      "82": 0.03227704018354416,
      "288": 0.03176761046051979,
      "466": 0.031480953097343445,
      "36": 0.031450312584638596,
      "204": 0.030573096126317978,
      "422": 0.030568119138479233,
      "339": 0.02975134365260601,
      "33": 0.029749440029263496,
      "186": 0.029392119497060776,
      "35": 0.02914775349199772,
      "249": 0.028177309781312943,
      "508": 0.0281395073980093,
      "121": 0.028062963858246803,
      "441": 0.02795802801847458,
      "31": 0.02774726413190365,
      "341": 0.027560217306017876,
      "97": 0.027513418346643448,
      "456": 0.026761643588542938,
      "153": 0.02674262225627899,
      "382": 0.02673453837633133,
      "361": 0.026545453816652298,
      "221": 0.02636880986392498,
      "256": 0.025757411494851112,
      "371": 0.02529013156890869
    }
  },
  "safety": {
    "trial_1_safety": 0.40646761655807495,
    "trial_2_safety": 0.40646761655807495
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47970467805862427
  }
}